Test Price
2,800 AED✅ Home Collection Available
NEB Gene Nemaline Myopathy Type 2, Autosomal Recessive Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189‑accredited NGS platform, reinforced by ISO 9001:2015 certification.
- Premium Logistics: Complimentary VIP mobile phlebotomy & temperature‑controlled cold‑chain home collection (8 AM – 11 PM) for whole blood, FTA cards, or extracted DNA.
- Clinical Guidance: Telephonic post‑test guidance with a DHA‑licensed genetic counsellor to interpret results and coordinate specialist referrals.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Nemaline myopathy type 2 is a rare autosomal recessive congenital myopathy caused by loss‑of‑function variants in the NEB gene. This next‑generation sequencing (NGS) test provides a definitive molecular diagnosis, enabling personalised management and informed family planning.
| Feature | Our Genetic Test | Closest Alternative (Muscle Biopsy) |
|---|---|---|
| Precision | 99.9% analytical sensitivity; single‑nucleotide variants, indels, and copy number variations across the entire NEB gene | Invasive; visualises nemaline rods but cannot identify specific NEB mutations |
| Methodology | Illumina® NGS with validated bioinformatics pipeline (ISO 15189) | Quadriceps or deltoid biopsy; electron microscopy & immunohistochemistry |
| Turnaround | 3–4 Weeks | 4–6 Weeks |
| Patient Experience | At‑home blood draw or FTA card; non‑invasive | Surgical incision under local anaesthesia; risk of scarring |
Physician Insight & Safety Protocols
“Genetic testing for NEB mutations is a powerful diagnostic tool that should always be interpreted alongside a thorough clinical assessment, family history, and neuromuscular examination. This test is not a substitute for a comprehensive specialist evaluation. Continue all prescribed treatments unless your doctor explicitly advises otherwise.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA License: 9294403)
⚠️ Medication Advisory
Critical Safety Notice
- Medication Warning: Do not discontinue or modify any prescribed medication, including corticosteroids, without consulting your treating physician.
- ER Red Flags: Seek immediate emergency care if you experience severe bleeding, fainting, difficulty breathing, or signs of anaphylaxis after sample collection.
Exclusion Criteria
Who Should Not Take This Test
- Known bleeding disorder or current anticoagulant therapy without medical clearance.
- Active skin infection at the collection site.
- Inability to provide informed consent.
Patient FAQ & Clinical Guidance
1. What is nemaline myopathy type 2?
This NGS test identifies NEB gene mutations causing nemaline myopathy type 2, a congenital muscle disease. Autosomal recessive inheritance means both gene copies must carry a pathogenic variant for the condition to manifest. Our report provides a clear molecular classification, aiding in prognosis and genetic counselling.
2. How accurate is this genetic test?
Our NGS platform achieves 99.9% analytical sensitivity, detecting single nucleotide variants and small indels across the entire NEB gene. Each variant is classified according to ACMG guidelines by our team of clinical molecular geneticists, ensuring a report you and your doctor can trust.
3. Is fasting or special preparation required?
No fasting is required; a blood sample or buccal swab can be collected at home by our DHA‑certified phlebotomist. We recommend providing a detailed clinical history and, if possible, a three‑generation pedigree chart during your pre‑genetic counselling session to optimise variant interpretation.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled with strict confidentiality, encrypted in transit and at rest, and accessible only to authorised clinical personnel.
Clinical & Logistical Metadata
| Test Name | NEB Gene Nemaline Myopathy Type 2, Autosomal Recessive Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood, FTA card, or extracted DNA (buccal swab accepted for paediatric cases) |
| Methodology Used | Illumina® Next-Generation Sequencing (NGS) with ISO 15189‑accredited bioinformatics pipeline |
| ICD-10-CM Code | G71.2 (Congenital myopathies) |
| LOINC Code | 76692-9 (NEB gene mutation analysis) |
| DHA Facility License & Address | License 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians